Oscillopsia: Pathophysiological mechanisms and treatment;Oscillopsies: Approches physiopathologique et thérapeutique

Revue Neurologique

Volumn 163, Issue 4, 2007, Pages 421-439

  Tilikete, C ^a,b   Pisella, L ^b   Pelisson D ^b   Vighetto, A ^a,b  

^a HÔPITAL NEUROLOGIQUE   (France)

^b INSERM   (France)

Author keywords

Eye movements; Nystagmus; Saccades; Spatial constancy; Vestibulo ocular reflex

Indexed keywords

3,4 DIAMINOPYRIDINE; 4 AMINOPYRIDINE; ACETAZOLAMIDE; BACLOFEN; BARBITURIC ACID DERIVATIVE; BOTULINUM TOXIN; CANNABIS; CARBAMAZEPINE; CLONAZEPAM; GABAPENTIN; ISONIAZID; MEMANTINE; PROPRANOLOL DERIVATIVE; SCOPOLAMINE; VALPROIC ACID; VIGABATRIN;

BODY MOVEMENT; COGNITION; CONGENITAL NYSTAGMUS; DRUG EFFICACY; EYE FIXATION; EYE MOVEMENT; EYE MOVEMENT DISORDER; GAZE; HEAD MOVEMENT; HUMAN; MUSCLE DISEASE; NEUROPHYSIOLOGY; OPTOKINETIC NYSTAGMUS; OPTOKINETIC STIMULATION; OSCILLOPSIA; PARIETAL LOBE; PATHOPHYSIOLOGY; RETINA; RETINA FOVEA; RETINA IMAGE; REVIEW; SACCADIC EYE MOVEMENT; SUPERIOR OBLIQUE MUSCLE; TEMPORAL LOBE; VESTIBULAR NYSTAGMUS; VESTIBULOOCULAR REFLEX; VISION; NEUROLOGIC DISEASE; NYSTAGMUS; PHYSIOLOGY; VISUAL ADAPTATION;

ADAPTATION, OCULAR; FIXATION, OCULAR; HUMANS; NERVOUS SYSTEM DISEASES; NYSTAGMUS, PATHOLOGIC; OCULAR MOTILITY DISORDERS; REFLEX, VESTIBULO-OCULAR; SACCADES;

EID: 34249979313     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0035-3787(07)90418-x     Document Type: Review

References (111)

1. ABADI RV, WHITTLE JP, WORFOLK R. (1999). Oscillopsia and tolerance to retinal image movement in congenital nystagmus. Invest Ophthalmol Vis Sci, 40: 339-345.
2. ACHESON JF, CASSIDY L, GRUNFELD EA et al. (2001). Elevated visual motion detection thresholds in adults with acquired ophthalmoplegia. Br J Ophthalmol, 85: 1447-1449.
3. ASCHOFF JC, CONRAD B, KORNHUBER HH. (1974). Acquired pendular nystagmus with oscillopsia in multiple sclerosis: a sign of cerebellar nuclei disease. J Neurol Neurosurg Psychiatry, 37: 570-577.
4. ASHE J, HAIN TC, ZEE DS, SCHATZ NJ. (1991). Microsaccadic flutter. Brain, 114: 461-472.
5. AVERBUCH-HELLER L, KORI AA, ROTTACH KG, DELL'OSSO LF, REMLER BF, LEIGH RJ. (1996). Dysfunction of pontine omnipause neurons causes impaired fixation: macrosaccadic oscillations with a unilateral pontine lesion. Neuroophthalmology, 16: 99-106.
6. AVERBUCH-HELLER L, TUSA RJ, FUHRY L et al. (1997). A double-blind controlled study of gabapentin and baclofen as treatment for acquired nystagmus. Ann Neurol, 41: 818-825.
7. BANDINI F, CASTELLO E, MAZZELLA L, MANCARDI GL, SOLARO C. (2001). "Gabapentin but not vigabatrin is effective in the treatment of acquired nystagmus in multiple sclerosis: How valid is the GABAergic hypothesis?" J Neurol Neurosurg Psychiatry, 71: 107-110.
8. BARTON JJ, COX TA. (1993). Acquired pendular nystagmus in multiple sclerosis: clinical observations and the role of optic neuropathy. J Neurol Neurosurg Psychiatry, 56: 262-267.
9. BARTON JJ, HUAMAN AG, SHARPE JA. (1994). Muscarinic antagonists in the treatment of acquired pendular and downbeat nystagmus: a double-blind, randomized trial of three intravenous drugs. Ann Neurol, 35: 319-325.
10. BATALLER L, GRAUS F, SAIZ A et al. (2001). Clinical outcome in adult onset idiopathic or paraneoplastic opsoclonus-myoclonus. Brain, 124: 437-443.
11. BEDELL H E, CURRIE DC. (1993). Extraretinal signals for congenital nystagmus. Invest Ophthalmol Vis Sci, 34: 2325-2332.
12. BERTHOZ A. (1997). Parietal and hippocampal contribution to topokinetic and topographic memory. Philos Trans R Soc Lond B Biol Sci, 352: 1437-1448.
13. BERTHOZ A. (1999). The brain, movement and space. Bull Mem Acad R Med Belg, 154: 405-412.
14. BLOUIN J, GAUTHIER GM, VAN DONKELAAR P, VERCHER JL. (1995). Encoding the position of a flashed visual target after passive body rotations. Neuroreport, 6: 1165-1168.
15. BOLGER C, BOJANIC S, SHEAHAN NF, COAKLEY D, MALONE JF. (1999). Dominant frequency content of ocular microtremor from normal subjects. Vision Res, 39: 1911-1915.
16. BRAZIS PW, MILLER NR, HENDERER JD, LEE AG. (1994). The natural history and results of treatment of superior oblique myokymia. Arch Ophthalmol, 112: 1063-1067.
17. BRIDGEMAN B, HENDRY D, STARK L. (1975). Failure to detect displacement of the visual world during saccadic eye movements. Vision Res, 15: 719-722.
18. BRIDGEMAN B, PALCA J. (1980). The role of microsaccades in high acuity observational tasks. Vision Res, 20: 813-817.
19. BRONSTEIN AM. (2004). Vision and vertigo: some visual aspects of vestibular disorders. J Neurol, 251: 381-387.
20. BURR DC, ROSS J. (1982). Contrast sensitivity at high velocities. Vision Res 22: 479-484.
21. CANNON SC, ROBINSON DA. (1987). Loss of the neural integrator of the oculomotor system from brain stem lesions in monkey. J Neurophysiol, 57: 1383-1409.
22. CASTET E, MASSON GS. (2000). Motion perception during saccadic eye movements. Nat Neurosci, 3: 177-183.
23. CASTILLO IG, REINECKE RD, SERGOTT RC, WIZOV S. (2004). Surgical treatment of trauma-induced periodic alternating nystagmus. Ophthalmology, 111: 180-183.
24. CIUFFREDA KJ, KENYON RV, STARK L. (1983). Saccadic intrusions contributing to reading disability: a case report. Am J Optom Physiol Opt, 60: 242-249.
25. COLBY CL, DUHAMEL JR, GOLDBERG ME. (1995). Oculocentric spatial representation in parietal cortex. Cereb Cortex, 5: 470-481.
26. COPPOLA D, PURVES D. (1996). The extraordinarily rapid disappearance of entopic images. Proc Natl Acad Sci U S A, 93: 8001-8004.
27. CREMER PD, HALMAGYI GM, AW ST et al. (1998). Semicircular canal plane head impulses detect absent function of individual semicircular canals. Brain, 121: 699-716.
28. DAS VE, ORUGANTI P, KRAMER PD, LEIGH RJ. (2000). Experimental tests of a neural-network model for ocular oscillations caused by disease of central myelin. Exp Brain Res, 133: 189-197.
29. DELL'OSSO LF. (1985). Congenital, latent and manifest latent nystagmus - similarities, differences and relation to strabismus. Jpn J Ophthalmol, 29: 351-368.
30. DELL'OSSO LF. (1991). Eye movements, visual acuity and spatial constancy. Acta Neurol Belg, 91: 105-113.
31. DELL'OSSO LF, VAN DER STEEN J, STEINMAN RM, COLLEWIJN H. (1992). Foveation dynamics in congenital nystagmus. II: Smooth pursuit. Doc Ophthalmol, 79: 25-49.
32. DELL'OSSO LF. (2000). Suppression of pendular nystagmus by smoking cannabis in a patient with multiple sclerosis. Neurology, 54: 2190-2191.
33. DELL'OSSO LF. (2002). Development of new treatments for congenital nystagmus. Ann N Y Acad Sci, 956: 361-379.
34. DEMER JL, HONRUBIA V, BALOH RW. (1994). Dynamic visual acuity: a test for oscillopsia and vestibulo-ocular reflex function. Am J Otol, 15: 340-347.
35. DEUBEL H, BRIDGEMAN B, SCHNEIDER WX. (1998). Immediate postsaccadic information mediates space constancy. Vision Res, 38: 3147-3159.
36. DIAPER CJ. (1997). Pulfrich revisited. Surv Ophthalmol, 41: 493-499.
37. DIETERICH M, GRUNBAUER WM, BRANDT T. (1998). Direction-specific impairment of motion perception and spatial orientation in down-beat and upbeat nystagmus in humans. Neurosci Lett, 245: 29-32.
38. DIETERICH M, STRAUBE A, BRANDT T, PAULUS W, BUTTNER U. (1991). The effects of baclofen and cholinergic drugs on upbeat and downbeat nystagmus. J Neurol Neurosurg Psychiatry, 54: 627-632.
39. DUFFY FH, BURCHFIEL JL. (1975). Eye movement-related inhibition of primate visual neurons. Brain Res, 89: 121-132.
40. DUHAMEL JR, COLBY CL, GOLDBERG ME. (1992). The updating of the representation of visual space in parietal cortex by intended eye movements. Science, 255: 90-92.
41. EIZENMAN M, CHENG P, SHARPE JA, FRECKER RC. (1990). End-point nystagmus and ocular drift: an experimental and theoretical study. Vision Res, 30: 863-877.
42. ENGBERT R, KLIEGL R. (2003). Microsaccades uncover the orientation of covert attention. Vision Res, 43: 1035-1045.
43. ETTLINGER G, WARRINGTON E, ZANGWILL OL. (1957). A further study of visual-spatial agnosia. Brain, 80: 335-361.
44. FOROOZAN R, BRODSKY MC. (2004). Microsaccadic opsoclonus: an idiopathic cause of oscillopsia and episodic blurred vision. Am J Ophthalmol, 138: 1053-1054.
45. FUKUSHIMA K. (1987). The interstitial nucleus of Cajal and its role in the control of movements of head and eyes. Prog Neurobiol, 29: 107-192.
46. GLASAUER S, KALLA R, BUTTNER U, STRUPP M, BRANDT T. (2005). 4-aminopyridine restores visual ocular motor function in upbeat nystagmus. J Neurol Neurosurg Psychiatry, 76: 451-453.
47. GOLDSTEIN HP, GOTTLOB I, FENDICK MG. (1992). Visual remapping in infantile nystagmus. Vision Res, 32: 1115-1124.
48. GOODALE MA, PELISSON D, PRABLANC C. (1986). Large adjustments in visually guided reaching do not depend on vision of the hand or perception of target displacement. Nature, 320: 748-750.
49. GOTTLIEB JP, KUSUNOKI M, GOLDBERG ME. (1998). The representation of visual salience in monkey parietal cortex. Nature, 391: 481-484.
50. GOTTLOB I. (2001). Nystagmus. Curr Opin Ophthalmol, 12: 378-383.
51. GRUNBAUER WM, DIETERICH M, BRANDT T. (1998). Bilateral vestibular failure impairs visual motion perception even with the head still. Neuroreport, 9: 1807-1810.
52. GRUNFELD EA, MORLAND AB, BRONSTEIN AM, GRESTY MA. (2000). Adaptation to oscillopsia: a psychophysical and questionnaire investigation. Brain, 123: 277-290.
53. HAARMEIER T, THIER P, REPNOW M, PETERSEN D. (1997). False perception of motion in a patient who cannot compensate for eye movements. Nature, 389: 849-852.
54. HALMAGYI GM, RUDGE P, GRESTY MA, LEIGH RJ, ZEE DS. (1980). Treatment of periodic alternating nystagmus. Ann Neurol, 8: 609-611.
55. HALMAGYI GM, CURTHOYS IS, CREMER PD, HENDERSON CJ, STAPLES M. (1990). Head impulses after unilateral vestibular deafferentation validate Ewald's second law. J Vestib Res, 1: 187-197.
56. HEIDE W, BLANKENBURG M, ZIMMERMANN E, KOMPF D. (1995). Cortical control of double-step saccades: implications for spatial orientation. Ann Neurol, 38: 739-748.
57. HELMCHEN C, SPRENGER A, RAMBOLD H, SANDER T, KOMPF D, STRAUMANN D. (2004). Effect of 3,4-diaminopyridine on the gravity dependence of ocular drift in downbeat nystagmus. Neurology, 63: 752-753.
58. HERTLE RW, FITZGIBBON EJ, AVALLONE JM, CHEESEMAN E, TSILOU EK. (2001). Onset of oscillopsia after visual maturation in patients with congenital nystagmus. Ophthalmology, 108: 2301-2307; discussion 2307-2308.
59. HOTSON JR. (1982). Cerebellar control of fixation eye movements. Neurology, 32: 31-36.
60. INGLE D. (1992). Spatial short-term memory: evolutionary perspectives and discoveries from split-brain studies. Behavorial and brain sciences, 15: 760-762.
61. ISHIKAWA S, OSAWA H et al. (1987). Treatment of nystagmus by acupuncture. Amsterdam, Aeolus Press.
62. ISRAEL I, FETTER M et al. (1993). Vestibular perception of passive whole-body rotation about horizontal and vertical axes in humans: goal-directed vestibulo-ocular reflex and vestibular memory-contingent saccades. Exp Brain Res, 96: 335-346.
63. JOHKURA K, KOMIYAMA A, KUROIWA Y. (2002). Pathophysiologic mechanism of convergence nystagmus. Eur Neurol, 47: 233-238.
64. KALLA R, GLASAUER S, SCHAUTZER F, LEHNEN N, BUTTNER U, STRUPP M, BRANDT T. (2004). 4-aminopyridine improves downbeat nystagmus, smooth pursuit, and VOR gain. Neurology, 62: 1228-1229.
65. KIM JI, AVERBUCH-HELLER L, LEIGH RJ. (2001). Evaluation of transdermal scopolamine as treatment for acquired nystagmus. J Neuroophthalmol, 21: 188-192.
66. KLIER EM, ANGELAKI DE, HESS BJ. (2005). Roles of gravitational cues and efference copy signals in the rotational updating of memory saccades. J Neurophysiol, 94: 468-478.
67. KOMIYAMA A, TODA H, JOHKURA K. (1999). Edrophonium-induced macrosaccadic oscillations in myasthenia gravis. Ann Neurol, 45: 522-525.
68. KOSMORSKY GS, ELLIS BD, FOGT N, LEIGH RJ. (1995). The treatment of superior oblique myokymia utilizing the Harada-Ito procedure. J Neuroophthalmol, 15: 142-146.
69. LEIGH RJ, RUSHTON DN, THURSTON SE, HERTLE RW, YANIGLOS SS. (1988). Effects of retinal image stabilization in acquired nystagmus due to neurologic disease. Neurology, 38: 122-127.
70. LEIGH RJ, DELL'OSSO LF, YANIGLOS SS, THURSTON SE. (1988). Oscillopsia, retinal image stabilization and congenital nystagmus. Invest Ophthalmol Vis Sci, 29: 279-282.
71. LEIGH RJ, TOMSAK RL, SEIDMAN SH, DELL'OSSO LF. (1991). Superior oblique myokymia. Quantitative characteristics of the eye movements in three patients. Arch Ophthalmol, 109: 1710-1713.
72. LEIGH RJ. (1992). Clinical features and pathogenesis of acquired forms of nystagmus. Baillieres Clin Neurol, 1: 393-416.
73. LEIGH RJ, TOMSAK RL, GRANT MP, REMLER BF, YANIGLOS SS, LYSTAD L, DELL'OSSO LF. (1992). Effectiveness of botulinum toxin administered to abolish acquired nystagmus. Ann Neurol, 32: 633-642.
74. LEIGH RJ, AVERBUCH-HELLER L, TOMSAK RL, REMLER BF, YANIGLOS SS, DELL'OSSO LF. (1994). Treatment of abnormal eye movements that impair vision: strategies based on current concepts of physiology and pharmacology. Ann Neurol, 36: 129-141.
75. LEIGH RJ, ZEE DS. (2001). The Neurology of Eye Movements. Philadelphia, F.A. Davis Company.
76. LEIGH RJ, TOMSAK RL. (2003). Drug treatments for eye movement disorders. J Neurol Neurosurg Psychiatry, 74: 1-4.
77. LOPEZ LI, BRONSTEIN AM, GRESTY MA, DU BOULAY EP, RUDGE P. (1996). Clinical and MRI correlates in 27 patients with acquired pendular nystagmus. Brain, 119: 465-472.
78. MORLAND AB, BRONSTEIN AM, RUDDOCK KH, WOODING DS. (1998). Oscillopsia: visual function during motion in the absence of vestibulo-ocular reflex. J Neurol Neurosurg Psychiatry, 65: 828-835.
79. MOVSAS TZ, LIU GT, GALETTA SL, BALCER LJ, VOLPE NJ. (2001). Current neuro-ophthalmic therapies. Neurol Clin, 19: 145-172, vii.
80. PAUS T, MARRETT S, WORSLEY KJ, EVANS AC. (1995). Extraretinal modulation of cerebral blood flow in the human visual cortex: implications for saccadic suppression. J Neurophysiol, 74: 2179-2183.
81. PISELLA L, BERBEROVIC N, MATTINGLEY JB. (2004). Impaired working memory for location but not for colour or shape in visual neglect: a comparison of parietal and non-parietal lesions. Cortex, 40: 379-390.
82. PISELLA L, MATTINGLEY JB. (2004). The contribution of spatial remapping impairments to unilateral visual neglect. Neurosci Biobehav Rev, 28: 181-200.
83. REPKA MX, SAVINO PJ, REINECKE RD. (1994). Treatment of acquired nystagmus with botulinum neurotoxin A. Arch Ophthalmol, 112: 1320-1324.
84. RIGGS LA, RATLIFF F, CORNSWEET JC, CORNSWEET TN. (1953). The disappearance of steadily fixated visual test objects. J Opt Soc Am, 43: 495-501.
85. ROBINSON DL, PETERSEN SE. (1992). The pulvinar and visual salience. Trends Neurosci, 15: 127-132.
86. ROSS J, MORRONE MC, GOLDBERG ME, BURR DC. (2001). Changes in visual perception at the time of saccades. Trends Neurosci, 24: 113-121.
87. ROSSETTI Y, PISELLA L, VIGHETTO A. (2003). Optic ataxia revisited: visually guided action versus immediate visuomotor control. Exp Brain Res, 153: 171-179.
88. SAFRAN AB, GAMBAZZI Y. (1992). Congenital nystagmus: rebound phenomenon following removal of contact lenses. Br J Ophthalmol, 76: 497-498.
89. SCHARWEY K, KRZIZOK T, SAMII M, ROSAHL SK, KAUFMANN H. (2000). Remission of superior oblique myokymia after microvascular decompression. Ophthalmologica, 214: 426-428.
90. SCHON F, HART PE, HODGSON TL, PAMBAKIAN AL, RUPRAH M, WILLIAMSON EM, KENNARD C. (1999). Suppression of pendular nystagmus by smoking cannabis in a patient with multiple sclerosis. Neurology, 53: 2209-2210.
91. SCHON F, HODGSON TL, MORT D, KENNARD C. (2001). Ocular flutter associated with a localized lesion in the paramedian pontine reticular formation. Ann Neurol, 50: 413-416.
92. SHALLO-HOFFMANN J, WOLSLEY CJ, ACHESON JF, BRONSTEIN AM. (1998). Reduced duration of a visual motion aftereffect in congenital nystagmus. Doc Ophthalmol, 95: 301-314.
93. SHETH NV, DELL'OSSO LF, LEIGH RJ, VAN DOREN CL, PECKHAM HP. (1995). The effects of afferent stimulation on congenital nystagmus foveation periods. Vision Res, 35: 2371-2382.
94. SPARKS D L, MAYS LE. (1990). Signal transformations required for the generation of saccadic eye movements. Annu Rev Neurosci, 13: 309-336.
95. STARCK M, ALBRECHT H, POLLMANN W, STRAUBE A, DIETERICH M. (1997). Drug therapy for acquired pendular nystagmus in multiple sclerosis. J Neurol, 244: 9-16.
96. STRAUBE A. (2005). Pharmacology of vertigo/nystagmus/ oscillopsia. Curr Opin Neurol, 18: 11-14.
97. STRAUBE A, LEIGH RJ, BRONSTEIN A et al. (2004). EFNS task force - therapy of nystagmus and oscillopsia. Eur J Neurol, 11: 83-9.
98. STRUPP M, KALLA R, DICHGANS M, FREILINGER T, GLASAUER S, BRANDT T. (2004). Treatment of episodic ataxia type 2 with the potassium channel blocker 4-aminopyridine. Neurology, 62: 1623-1625.
99. STRUPP M, SCHULER O, KRAFCZYK S, JAHN K, SCHAUTZER F, BUTTNER U, BRANDT T. (2003). Treatment of downbeat nystagmus with 3,4-diaminopyridine: A placebo-controlled study. Neurology, 61: 165-170.
100. THIER P, HAARMEIER T, CHAKRABORTY S, LINDNER A, TIKHONOV A. (2001). Cortical substrates of perceptual stability during eye movements. Neuroimage, 14: S33-S39.
101. TIECKS FP, PLANCK J, HABERL RL, BRANDT T. (1996). Reduction in posterior cerebral artery blood flow velocity during caloric vestibular stimulation. J Cereb Blood Flow Metab, 16: 1379-1382.
102. TILIKET C, VENTRE-DOMINEY J, VIGHETTO A, GROCHOWICKI M. (1996). Room tilt illusion. A central otolith dysfunction. Arch Neurol, 53: 1259-1264.
103. TILIKETE C, VIGHETTO A. (2003). Nystagmus. Encycl Méd Chir, Neurologie (17-016-A-60): 15 p.
104. TYLER TD, RUIZ RS. (1990). Propranolol in the treatment of superior oblique myokymia. Arch Ophthalmol, 108: 175-176.
105. WENZEL R, BARTENSTEIN P, DIETERICH et al. (1996). Deactivation of human visual cortex during involuntary ocular oscillations. A PET activation study. Brain, 119: 101-110.
106. WENZEL R, WOBST P, HEEKEREN HH et al. (2000). Saccadic suppression induces focal hypooxygenation in the occipital cortex. J Cereb Blood Flow Metab, 20: 1103-1110.
107. WIST ER, BRANDT T, KRAFCZYK S. (1983). Oscillopsia and retinal slip. Evidence supporting a clinical test. Brain, 106: 153-168.
108. YANIGLOS SS, RJ LEIGH. (1992). Refinement of an optical device that stabilizes vision in patients with nystagmus. Optom Vis Sci, 69: 447-450.
109. YOUSRY I, DIETERICH M, NAIDICH TP, SCHMID UD, YOUSRY TA. (2002). Superior oblique myokymia: magnetic resonance imaging support for the neurovascular compression hypothesis. Ann Neurol, 51: 361-368.
110. ZEE DS. (1978). Ophthalmoscopy in examination of patients with vestibular disorders. Ann Neurol, 3: 373-374.
111. ZEE DS, YAMAZAKI A, BUTLER PH, GUCER G. (1981). Effects of ablation of flocculus and paraflocculus of eye movements in primate. J Neurophysiol, 46: 878-899.